Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

Clinical trial NCT06764238 · RECRUITING

Trial details

NCT number: NCT06764238
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia ALL Childhood Leukemia, Acute Lymphoblastic B Cell Acute Lymphoblastic Leukemia (B-ALL)

Start date: 2025-01-03
Primary completion: 2029-12-31
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.